Acceptance and Commitment Therapy for Informal Caregivers of People With Dementia (ACT-IC)

May 8, 2024 updated by: Maastricht University Medical Center

A Blended Intervention Based on Acceptance and Commitment Therapy (ACT) for Informal Caregivers of People With Dementia- A Mixed-method Approach to Evaluate Feasibility, Acceptability and Preliminary Effectiveness

Dementia has a major impact on people with dementia and their family. Informal caregivers of people with dementia are at higher risk of developing depressive symptoms compared to informal caregivers of people with other chronic diseases. Therefore, supporting this group of informal caregivers is particularly important. With an online program based on Acceptance and Commitment Therapy (ACT), this study supports caregivers of people with dementia to lead a more meaningful and less stressful life. In addition to following the online program, caregivers are supported weekly by a coach, who helps to set goals, map important values in life, and take actions in relevant areas. The current study aims to examine the (1) feasibility and acceptability of the intervention and its procedure and; (2) preliminary effectiveness of the intervention on clinical outcomes (e.g. psychological flexibility and self-competence); and (3) maintenance of change after the intervention in short-and long-term follow-ups. This study includes a single-arm, non-randomized trial with a baseline assessment, a 9-week internet-based intervention period, a post-intervention assessment, and two follow-ups at 3 and 6 months. ACT is a promising form of therapy that has previously been shown to be effective in increasing the mental well-being of caregivers. However, this is the first study to combine online ACT modules, goal-setting, and weekly coaching for informal caregivers of people with dementia.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Maastricht, Limburg, Netherlands, 6229 ET
        • Maastricht University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adult informal caregivers (at least 18 years old)
  • Access to the internet and having a tablet or computer
  • Self-identified primary informal caregiver of a person diagnosed with dementia
  • Taking care of the care recipient at least once a week for a period of at least three months
  • Obtained informed consent *General (psychological) support from case managers will not count as professional psychological support, and therefore, informal caregivers who receive support from the case managers will also be included.

Exclusion Criteria:

  • Caregivers who report having a cognitive disorder in their clinical record will be excluded (based on self-report).
  • Caregivers who receive psychotherapy or psychopharmacological treatment within the last 3 months will be excluded (based on self-report).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single-arm non-randomised
This study includes a baseline assessment, a 9-week (with the possibility of extension to 12 weeks) blended intervention period, a post-intervention assessment, and two follow-ups at 3 and 6 months. Informal caregivers of people with dementia (with at least 18-year-old) with no restriction in terms of sex, educational level, or ethnic background will be included.

Blended intervention includes completing 9 e-modules consist of written material, videos, and assignments (one e-module per week) that can be completed over 9 to 12 weeks AND 9 (to 12 ) coaching sessions (telephone call). Weekly coaching will be offered by a motivational coach based in Maastricht University.

After the post-intervention assessments, individuals will receive monthly calls from the motivational coach as "booster sessions". Booster sessions will be received on monthly basis for a period of 6 months (one session per month) and until the last follow-up assessment. Communication with participants will take place online or via telephone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessing change in depression, anxiety, and stress
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Measure the emotional states of depression, anxiety and stress will be assessed by DASS-21 self-report questionnaire. DASS-21 has three sections (7-items per section) that measure depression, anxiety, and stress on a 4-point Likert scale (0= the statement did not apply to me at all, 4= the statement applied to me very much or most of the time. DASS-21 is a validated scale that has been used in previous studies and has been recommended for measuring the dimensions of depression, anxiety, and stress.
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Assessing change in sense of competence
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Informal caregivers' sense of competence indicates the feelings of being capable of caring for a person with dementia. Short Sense of Competence Questionnaire (SSCQ) is a valid and reliable scale which has been used in previous studies with a similar target population and consists of seven items rated on a 5-point scale from 1 ("agree very strongly") to 5 ("disagree very strongly")
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Assessing change in self efficacy
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
The Caregiver Self-Efficacy Scale (CSES) is based on a Dutch adaptation of the Lorig et al. CSES evaluates caregiver self-efficacy (four item) and service-use self-efficacy (five items) and item scores range from 1 (uncertain) to 10 (very certain). Previous research has shown that CSES is valid and reliable
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Assessing change in perceived burden
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Caregiver burden will be measured by a one-item questionnaire. The perseverance-time question will ask: if the informal caregiver's current situation persists, for how long (in month) the informal caregiver thinks they are able to maintain caregiving. This questionnaire is a good predictor for institutionalisation.
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention..
Acceptability
Time Frame: Will be assessed after completing the 9-week intervention
Will be assessed qualitatively during a semi-structured interview based on Program Participation Questionnaire (PPQ)
Will be assessed after completing the 9-week intervention
Perceived feasibility
Time Frame: Will be assessed after completing each module (during the intervention). 9 time for 9 modules.
Brief self-report feasibility questionnaire
Will be assessed after completing each module (during the intervention). 9 time for 9 modules.
Perceived feasibility and acceptability
Time Frame: After the last follow up assessment (6-month)
Will be assessed qualitatively during the semi-structured interview
After the last follow up assessment (6-month)
Attrition
Time Frame: During the study (duration of study is expected to be 1.5 year)
Number of drop outs of study after collecting informed consent
During the study (duration of study is expected to be 1.5 year)
Perceived feasibility and acceptability
Time Frame: 9 (to 12) times. One telephone call per week over 9 (to 12) weeks of intervention.
Will be assessed qualitatively during coaching sessions
9 (to 12) times. One telephone call per week over 9 (to 12) weeks of intervention.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessing change in psychological flexibility
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Psychological flexibility is defined as the ability to be accepting, flexible and conscious in facing challenging situations and the ability to stay engaged with valued activities. This factor will be assessed by Acceptance and Action Questionnaire II, (AAQ-II) which has been reported to be valid, reliable and psychometrically consistent . 10 Items are scored on a 7-point Likert scale and higher scores indicate more psychological flexibility
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Assessing change in resilience
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Changes in psychological flexibility and functional coping with negative thoughts and feelings in informal caregivers will be assessed using the Flexibility Index Test (FIT-60). This reliable and valid questionnaire will assess six different ACT processes (acceptance, diffusion, self as context, attention to present moment and values, and dedicated action) and can monitor the progress of the ACT therapy. The questionnaire consists of 60 items and is scored on a seven-point Likert scale (0= completely disagree, 6= completely agree). Higher score reflects on higher psychological flexibility.
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Assessing change in values
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Important areas of life will be identified by the Valued Living Questionnaire (VLQ), which individuals rate level of importance of 12 different areas (e.g. family, work) on 10-point Likert scale (1= the area is not important at all, 10= the area is very important). The most important area will be considered as individuals' "value" at their current stage of life. The psychometric properties have been investigated in previous studies.
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Assessing change in committed actions
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
The extent to which individuals have been actively living in accordance with their values will be assessed by the Engaged Living Scale (ELS). ELS has been recommended for assessing committed actions and value engagement . ELS consists of 16-items in which individual should reflect in statements based on 5-point Likert scale (1=strongly disagree, 5= strongly agree)
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Assessing change in gaol attainment
Time Frame: Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.
Goal-attainment scaling will be conducted qualitatively and will be measured as part of the weekly coaching and booster sessions. Level of goal achievement since the last coaching session and the extent to which participants could achieve their goals at expected level will be discussed
Will be assessed at baseline, after completing the intervention (9 to 12 weeks), 3month after intervention, and 6 month after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2022

Primary Completion (Actual)

May 20, 2023

Study Completion (Actual)

November 20, 2023

Study Registration Dates

First Submitted

September 3, 2021

First Submitted That Met QC Criteria

September 23, 2021

First Posted (Actual)

October 1, 2021

Study Record Updates

Last Update Posted (Actual)

May 10, 2024

Last Update Submitted That Met QC Criteria

May 8, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Dara will be shared and handled based on the data management plan supported by the Clinical Trial Centre Maastricht.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on No Specific Conditions

Clinical Trials on Blended intervention based in acceptance and commitment therapy

Subscribe